Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11339130 Calpain modulators and therapeutic uses thereof

Patent 11339130 was granted and assigned to Blade Therapeutics on May, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

113391300

Patent Inventor Names

Shendong Yuan0

John Beamond Nicholas0

Kumaraswamy Emayan0

Marc Adler0

Brad Owen Buckman0

Jingyuan Ma0

Date of Patent

May 24, 2022

Patent Application Number

170325290

Date Filed

September 25, 2020

Patent Citations

‌

US Patent 10590084 Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof

‌

US Patent 10934261 Calpain modulators and therapeutic uses thereof

Patent Primary Examiner

‌

Joseph R Kosack

Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11339130 Calpain modulators and therapeutic uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API